TCAIM

gene
On this page

Also known as DKFZp313N0621TOAG-1

Summary

TCAIM (T cell activation inhibitor, mitochondrial, HGNC:25241) is a protein-coding gene on chromosome 3p21.31, encoding T-cell activation inhibitor, mitochondrial (Q8N3R3). May regulate T-cell apoptosis.

Located in mitochondrion.

Source: NCBI Gene 285343 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 64 total
  • MANE Select transcript: NM_173826

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25241
Approved symbolTCAIM
NameT cell activation inhibitor, mitochondrial
Location3p21.31
Locus typegene with protein product
StatusApproved
AliasesDKFZp313N0621, TOAG-1
Ensembl geneENSG00000179152
Ensembl biotypeprotein_coding
OMIM620787
Entrez285343

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 11 protein_coding, 3 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000342649, ENST00000383746, ENST00000396078, ENST00000412611, ENST00000417237, ENST00000417768, ENST00000431657, ENST00000444602, ENST00000462230, ENST00000462612, ENST00000469246, ENST00000494638, ENST00000876546, ENST00000876547, ENST00000876548, ENST00000876549, ENST00000876550, ENST00000876551

RefSeq mRNA: 6 — MANE Select: NM_173826 NM_001029839, NM_001029840, NM_001282913, NM_001282914, NM_001282915, NM_173826

CCDS: CCDS2712, CCDS43076

Canonical transcript exons

ENST00000342649 — 11 exons

ExonStartEnd
ENSE000012184524436745644367708
ENSE000034618024440744244409448
ENSE000034787524435473944354811
ENSE000035163204440120344401334
ENSE000036053744435774144357876
ENSE000036219274440035544400587
ENSE000036240054439640044396497
ENSE000036675854436136544361518
ENSE000036771674439674344396834
ENSE000036913934439285544392977
ENSE000038494684433876644338834

Expression profiles

Bgee: expression breadth ubiquitous, 249 present calls, max score 91.19.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.2767 / max 107.6608, expressed in 1809 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
363208.15771746
363238.03771730
363243.14311393
363210.7957525
363220.142545

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111491.19gold quality
liverUBERON:000210790.47gold quality
hindlimb stylopod muscleUBERON:000425289.30gold quality
adrenal tissueUBERON:001830389.05gold quality
C1 segment of cervical spinal cordUBERON:000646988.67gold quality
islet of LangerhansUBERON:000000688.48gold quality
ventricular zoneUBERON:000305388.36gold quality
muscle of legUBERON:000138388.29gold quality
gastrocnemiusUBERON:000138887.79gold quality
ganglionic eminenceUBERON:000402387.79gold quality
spinal cordUBERON:000224087.73gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.40gold quality
deltoidUBERON:000147687.38gold quality
secondary oocyteCL:000065587.14gold quality
tibialis anteriorUBERON:000138587.10gold quality
esophagus squamous epitheliumUBERON:000692086.92gold quality
metanephros cortexUBERON:001053386.88gold quality
smooth muscle tissueUBERON:000113586.87gold quality
calcaneal tendonUBERON:000370186.86gold quality
monocyteCL:000057686.72gold quality
oocyteCL:000002386.71gold quality
amniotic fluidUBERON:000017386.49gold quality
leukocyteCL:000073886.46gold quality
adult mammalian kidneyUBERON:000008286.33gold quality
cortex of kidneyUBERON:000122586.28gold quality
skeletal muscle tissueUBERON:000113486.20gold quality
biceps brachiiUBERON:000150786.08gold quality
gall bladderUBERON:000211085.85gold quality
rectumUBERON:000105285.76gold quality
colonic epitheliumUBERON:000039785.25gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.79
E-MTAB-4850no93.46

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

111 targeting TCAIM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-5692A100.0074.406850
HSA-MIR-8485100.0077.574731
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-3924100.0072.092394
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-4262100.0073.263931
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-126-5P100.0072.713180
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-477599.9875.006394
HSA-MIR-570-3P99.9672.414910
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-335-3P99.9373.364958
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-205-3P99.9269.923165
HSA-MIR-497-5P99.9271.832674
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-195-5P99.9072.812805

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriotcaimENSDARG00000079881
mus_musculusTcaimENSMUSG00000046603
rattus_norvegicusTcaimENSRNOG00000004085
drosophila_melanogasterCG13295FBGN0035674
drosophila_melanogasterCG2854FBGN0040391
caenorhabditis_elegansWBGENE00016438

Protein

Protein identifiers

T-cell activation inhibitor, mitochondrialQ8N3R3 (reviewed: Q8N3R3)

Alternative names: Tolerance associated gene-1 protein

All UniProt accessions (2): Q8N3R3, A0A0U1RQT4

UniProt curated annotations — full annotation on UniProt →

Function. May regulate T-cell apoptosis.

Subcellular location. Mitochondrion.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoforms (4)

UniProt IDNamesCanonical?
Q8N3R3-11yes
Q8N3R3-22
Q8N3R3-33
Q8N3R3-44

RefSeq proteins (6): NP_001025010, NP_001025011, NP_001269842, NP_001269843, NP_001269844, NP_776187* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR027986TCAIMFamily
IPR027989DUF4461Domain
IPR028031DUF4460Domain

Pfam: PF14687, PF14688

UniProt features (29 total): helix 9, strand 9, splice variant 5, sequence conflict 2, chain 1, coiled-coil region 1, turn 1, sequence variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
8I0KELECTRON MICROSCOPY2.86

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N3R3-F179.770.47

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 96 (showing top): TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, HNF4_DR1_Q3, YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, CSR_EARLY_UP.V1_DN, BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP, chr3p21, CIITA_TARGET_GENES, F10_TARGET_GENES, HOXA7_TARGET_GENES, HOXB6_TARGET_GENES, ID2_TARGET_GENES, NFE2L1_TARGET_GENES, NFKBIA_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

412 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TCAIMPTH2Q96A98510
TCAIMSMIM12Q96EX1459
TCAIMCLEC2LP0C7M8438
TCAIMBEND7Q8N7W2438
TCAIMITGA8P53708412
TCAIMZC3H8Q8N5P1409
TCAIMLRRC40Q9H9A6407
TCAIMSHISA4Q96DD7406
TCAIMBTBD8Q5XKL5404
TCAIMPAMR1Q6UXH9403
TCAIMFAM177A1Q8N128402
TCAIMMNMIP1A4FU49398
TCAIMKRT36O76013386
TCAIMMAN1A1P33908382
TCAIMTIMM21Q9BVV7381

IntAct

3 interactions, top by confidence:

ABTypeScore
TCAIMKGD4psi-mi:“MI:0914”(association)0.350
TCAIMcutApsi-mi:“MI:0915”(physical association)0.000

BioGRID (6): TCAIM (Proximity Label-MS), MRPS36 (Affinity Capture-MS), OGDHL (Affinity Capture-MS), OGDH (Affinity Capture-MS), TCAIM (Affinity Capture-MS), TCAIM (Affinity Capture-MS)

ESM2 similar proteins: A1A4J7, A2BID5, A2RRP1, A2RV06, B5DF07, E7FAW3, O00750, O15091, O35821, O70167, O70173, O75153, O75800, O76024, O88480, P0DKR2, P82650, Q08CY4, Q1LXZ7, Q28HN9, Q4R366, Q4R7V1, Q58CX2, Q5SW19, Q5TYW4, Q5U249, Q5XGL1, Q66JZ4, Q6AXZ5, Q6DRB1, Q6GPP1, Q7L8L6, Q7TPV4, Q811I0, Q86VS3, Q8BIR2, Q8C7B8, Q8CJF7, Q8IYW2, Q8JZY4

Diamond homologs: P0DKR2, Q66JZ4, Q8N3R3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

64 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance48
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1792 predictions. Top by Δscore:

VariantEffectΔscore
3:44358299:T:Gdonor_gain1.0000
3:44361364:GGAA:Gacceptor_gain1.0000
3:44361519:G:GAdonor_loss1.0000
3:44361519:G:GGdonor_gain1.0000
3:44361520:TACG:Tdonor_loss1.0000
3:44367530:A:AGacceptor_gain1.0000
3:44367531:G:GGacceptor_gain1.0000
3:44367707:ACG:Adonor_loss1.0000
3:44367709:G:Tdonor_loss1.0000
3:44367709:GTAT:Gdonor_gain1.0000
3:44367710:T:Gdonor_loss1.0000
3:44392850:TCTA:Tacceptor_loss1.0000
3:44392852:TA:Tacceptor_loss1.0000
3:44392853:A:AGacceptor_gain1.0000
3:44392853:AG:Aacceptor_loss1.0000
3:44392854:G:GGacceptor_gain1.0000
3:44392854:GA:Gacceptor_gain1.0000
3:44392854:GAT:Gacceptor_gain1.0000
3:44392854:GATC:Gacceptor_gain1.0000
3:44392976:AGG:Adonor_loss1.0000
3:44392977:GGTAA:Gdonor_loss1.0000
3:44392978:G:GAdonor_loss1.0000
3:44392979:T:Adonor_loss1.0000
3:44396493:AAAAG:Adonor_loss1.0000
3:44396494:AAAGG:Adonor_loss1.0000
3:44396495:AAG:Adonor_loss1.0000
3:44396496:AGG:Adonor_loss1.0000
3:44396497:GG:Gdonor_loss1.0000
3:44396498:G:Adonor_loss1.0000
3:44396499:T:Adonor_loss1.0000

AlphaMissense

3311 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:44396401:T:AW233R0.997
3:44396401:T:CW233R0.997
3:44396826:T:AW293R0.997
3:44396826:T:CW293R0.997
3:44357841:C:GH44D0.995
3:44361458:T:CF87L0.995
3:44361459:T:CF87S0.995
3:44361460:T:AF87L0.995
3:44361460:T:GF87L0.995
3:44396446:A:CS248R0.995
3:44396448:T:AS248R0.995
3:44396448:T:GS248R0.995
3:44357853:T:CF48L0.994
3:44357855:T:AF48L0.994
3:44357855:T:GF48L0.994
3:44361380:T:CS61P0.994
3:44361384:T:CL62P0.994
3:44361393:T:CL65S0.994
3:44396441:T:CL246P0.994
3:44357827:T:CF39S0.993
3:44357839:T:AV43E0.993
3:44361373:T:AN58K0.993
3:44361373:T:GN58K0.993
3:44357818:T:CL36S0.992
3:44357843:T:AH44Q0.992
3:44357843:T:GH44Q0.992
3:44396828:G:CW293C0.991
3:44396828:G:TW293C0.991
3:44396413:T:AW237R0.990
3:44396413:T:CW237R0.990

dbSNP variants (sampled 300 via entrez): RS1000085646 (3:44356921 C>A), RS1000102677 (3:44351077 A>G), RS1000137924 (3:44356648 C>G), RS1000140133 (3:44377915 A>C), RS1000170770 (3:44356298 G>A), RS1000172725 (3:44338923 T>G), RS1000220857 (3:44338782 T>C,G), RS1000254671 (3:44401948 G>C), RS1000280920 (3:44378208 C>A), RS1000364825 (3:44409367 A>G), RS1000366325 (3:44364049 C>T), RS1000422052 (3:44371388 T>C), RS1000438523 (3:44409832 C>T), RS1000471343 (3:44340471 T>C,G), RS1000496480 (3:44388200 T>C,G)

Disease associations

OMIM: gene MIM:620787 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST005839_8Depression5.000000e-08
GCST009600_32Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)4.000000e-08
GCST011494_83Daytime nap1.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007828daytime rest measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, decreases methylation5
Acetaminophendecreases expression3
bisphenol Aincreases expression2
sodium arsenitedecreases expression2
entinostatdecreases expression, affects cotreatment2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Cyclosporineincreases expression, decreases expression2
dicrotophosdecreases expression1
methylmercuric chloridedecreases expression1
trichostatin Adecreases expression1
butyraldehydedecreases expression1
manganese chlorideincreases abundance, increases expression1
pentanaldecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression, increases expression1
belinostatdecreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
dorsomorphinaffects cotreatment, decreases expression, increases expression1
(+)-JQ1 compoundincreases expression1
Zoledronic Acidincreases expression1
Amiodaroneincreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Catechinaffects cotreatment, increases expression1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Estradiolincreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Manganeseincreases abundance, increases expression1
Methyl Methanesulfonateincreases expression1
Tretinoindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.